Stason Pharmaceuticals recalls
FDA enforcement reports naming Stason Pharmaceuticals, Inc. as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Mar 13, 2024
- Mar 13, 2024Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02),…Drug · Stason Pharmaceuticals, Inc.Failed Dissolution Specifications: results slightly under spec at at 9-months.Class III
- Sep 14, 2016Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pha…Drug · Stason Pharmaceuticals, Inc.Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.Class III